544220 — Clinitech Laboratory Income Statement
0.000.00%
Last trade - 00:00- IN₹89.01m
- IN₹58.27m
- IN₹82.35m
Annual income statement for Clinitech Laboratory, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 45.5 | 63.8 | 63.5 | 64 | 82.3 |
| Cost of Revenue | |||||
| Gross Profit | 35.4 | 49.4 | 51.8 | 53 | 66.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 39.6 | 56.4 | 54.4 | 58.4 | 78.5 |
| Operating Profit | 5.9 | 7.4 | 9.09 | 5.67 | 3.82 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 5.46 | 7.02 | 8.64 | 5.05 | 5.55 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.02 | 5.13 | 6.13 | 3.71 | 3.95 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.02 | 5.13 | 6.13 | 3.71 | 3.95 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.02 | 5.13 | 6.13 | 3.71 | 3.95 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.76 | 2.25 | 2.69 | 1.59 | 1.9 |
| Dividends per Share |